Key Insights

Highlights

Success Rate

71% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 59/100

Termination Rate

16.7%

2 terminated out of 12 trials

Success Rate

71.4%

-15.1% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed with results

Key Signals

2 with results71% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (8)
P 2 (2)

Trial Status

Completed5
Terminated2
Recruiting2
Not Yet Recruiting2
Unknown1

Trial Success Rate

71.4%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (12)

Research Network

Activity Timeline